Gynecol Oncol. 2006 Apr;101(1):4-11.
A study to evaluate the use of CA125 in ovarian cancer follow-up: A change in practice led by patient preference.
Authors:
Palmer C,
Department of Oncology, Cambridge Gynae-Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Box 193, Hills Road, Cambridge CB2 2Q, UK. cherylannepalmer@doctors.net.uk To evaluate the use of CA125 in the follow-up of women with epithelial ovarian cancer in the Cambridge Gynaecologic Oncology Centre. To institute changes depending on patients' preferences.
A patientQuestionnaire was developed on follow-up, CA125 estimation and patient education in epithelial ovarian cancer and CA125. Initially, 100 patients were evaluated, and a change in practice was instituted. This was re-evaluated using the same patient population. 22/22 patients in clinic, and 68/78 patients who received the questionnaire by post, completed and returned it (n = 90). 81% wanted CA125 results available at clinic follow-up visits, with 82% willing to have the blood test done at their GP surgery before attending outpatients. CA125 follow-up practice was changed accordingly. This change was re-evaluated. A second questionnaire was sent to 35 surviving patients from the first cohort. 31/35 (90%) responses were received. Five patients were either no longer on follow-up, being > or =5 years from completing their original treatment or were being monitored elsewhere, leaving an 87% response rate (26/30). 92.3% felt that having CA125 results available in clinic had enhanced the quality of their follow-up. Patient education and basic understanding of CA125 also improved, with 88.5% aware of its role. The availability of CA125 results when patients attend for routine follow-up has improved their overall management in our clinics. It has reduced patient and physician anxiety and unsatisfactory out-of-clinic telephone communication. We recommend this change of practice to all Gynaecologic Oncology Centres engaged in active routine follow-up of their patients with epithelial ovarian cancer.
Please click on the required question. Objectives:
Methods:
Results:
Conclusions:
Reducing the Risks of Womens' Cancers.
Cancer of the Cervix.
Endometrial Cancer (Uterus)
Cancer of the Ovary.
The Treatment Of Womens' Cancers
Cancer of the Vulva, Vagina and Fallopian Tube
Breast Cancer
Web sites and Support Groups
Thank you for choosing to visit us.
This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London - Specialist Interests - Reproductive Medicine including Infertility, PCOS, PMS, Menopause and HRT.
I do hope that you find the answers to your women's health questions in the patient information and medical advice provided.




